Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DALBAVANCIN vs DALTEPARIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DALBAVANCIN vs DALTEPARIN: Safety Overview

Metric DALBAVANCIN DALTEPARIN
Total FAERS Reports 1,107 3,570
Deaths Reported 54 789
Death Rate 4.9% 22.1%
Hospitalizations 288 1,443
Average Patient Age 61.0 yrs 67.7 yrs
% Female Patients 46.7% 39.7%
FDA Approval Date May 23, 2014 Apr 4, 2002
Manufacturer Fresenius Kabi USA, LLC Pfizer Laboratories Div Pfizer Inc
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription